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Abstract 
Alcoholism is transmitted in families. The complexity and heterogeneity of this disorder has made it 
difficult to identify specific genetic correlates. One design with the potential to do so is the family-
based association study, in which the frequencies of genetic polymorphisms are compared between 
affected and nonaffected members. Reduced central serotonin neurotransmission is associated with 
features of an antisocial subtype of alcoholism, although a primary deficit has not been traced to a 
particular component. Genetic markers related to the sertonergic system have been identified, lo-
cated, and cloned. If associations can be discovered, the development process for pharmacotherapy 
could be facilitated. In this review, the evidence for the involvement of the serotonergic system in 
antisocial alcoholism is examined, and the potential for family-based association studies to identify 
specific components that may be involved is discussed. 
 
Although the familial nature of alcoholism has been recognized for quite some time (Cot-
ton, 1979; Goodwin, 1979), it is clear that the transmission of alcoholism across generations 
H I L L  E T  A L . ,  E X P E R I M E N T A L  A N D  C L I N I C A L  P S Y C H O P H A R M A C O L O G Y  7  (1 9 9 9 )  
2 
does not follow a simple monogenic Mendelian pattern (Stone & Gottesman, 1993). Alco-
holism is one of many complex traits whose complicated patterns of inheritance make it 
very difficult for geneticists to identify specific mechanisms that may confer vulnerability 
(Lander & Schork, 1994). An important step in the genetic dissection of alcoholism will be 
to define the phenotype restrictively, thereby decreasing the likelihood that variation among 
types of alcoholism (each with potentially different genetic correlates) will obscure pat-
terns that may be seen when a more homogeneous sample is tested (Lander & Schork, 1994). 
Given that familial patterns of alcoholism are complex, it may be desirable to use a 
method of genetic analysis that does not directly rely on inheritance patterns. Association 
studies allow one to ask whether a certain allele occurs at a higher frequency in affected 
individuals than it does in unaffected individuals in a population. Therefore, in association 
studies, in contrast to linkage studies, family history data are not usually collected. If a 
certain allele at a candidate gene locus occurs more frequently in the affected individuals 
than it does in the controls, it suggests that the particular allele plays a role in the pheno-
type of interest (Lander & Schork, 1994). In linkage studies, models of transmission are 
fitted to family pedigrees containing the trait of interest, and the mode of inheritance needs 
to be specified, but nothing need be known about specific genetic correlates of the trait. On 
the other hand, in association studies, nothing need be known about the mode of inher-
itance, but specific candidate genes need to be identified (Lander & Schork, 1994). Recent 
advances in understanding the phenotype of alcoholism and in molecular genetics of the 
serotonergic system have made such association studies feasible for alcoholism. 
In this article, we review an approach to defining the phenotype that may result in a 
clearer understanding of the genetic basis of alcoholism than is currently available. We 
examine the potential role of the serotonergic system in one type of alcoholism by first 
examining some of the evidence for a genetic basis for alcoholism. Next, we review some 
of the evidence for a homogeneous subtype of alcoholism, which should enable research-
ers to define alcoholism phenotypes better, which in turn will make detailed genetic anal-
ysis possible. We then review the evidence for an association between the serotonergic 
system and antisocial alcoholism and discuss the potential for association studies (i.e., can-
didate gene analysis) with respect to components of the serotonergic system and antisocial 
alcoholism. Finally, we address the issue of pharmacologic intervention targeted at the 
serotonergic system that might result in the development of a more effective treatment for 
alcoholism. In this article, alcoholism refers to the psychiatric disorder of alcohol depend-
ence. Specific symptoms and subtypes within this heterogeneous disorder are discussed 
as relevant. 
 
Genetic Basis of Alcoholism 
 
It has long been recognized that the occurrence of alcoholism (alcohol abuse or depend-
ence) is clustered within families. However, the majority of offspring of alcohol-dependent 
parents do not develop similar problems with alcohol, and only about one third develop 
alcohol dependence (Cotton, 1979; Goodwin, 1979). It has been very difficult to identify 
precise biological mechanisms that are associated with familial alcoholism. Candidates 
have ranged from physiological or psychological responses to alcohol (Schuckit, 1980) to 
H I L L  E T  A L . ,  E X P E R I M E N T A L  A N D  C L I N I C A L  P S Y C H O P H A R M A C O L O G Y  7  (1 9 9 9 )  
3 
differences in temperamental characteristics, such as emotionality or sociability (Tarter, 
Alterman, & Edwards, 1985). More direct evidence that alcoholism has a specific genetic 
basis comes from three research areas: twin studies, adoption studies, and genetic marker 
studies of association and linkage (Devor & Cloninger, 1989; McGue, 1994; Merikangas, 
1990). However, results from twin studies are difficult to generalize; virtually all of the 
adoption studies have been highly criticized for cursory specification of possible environ-
mental or intrauterine influences, diagnostic criteria, and statistical analyses (Littrell, 1988; 
Searles, 1988; Zucker, 1987); moreover, recent linkage studies are not consistent (Long et al., 
1998; Reich et al., 1998). In general, twin studies show a higher alcoholism concordance in 
monozygotic than dizygotic twins (beginning with Kaij, 1960), and adoption studies show 
a larger influence of biological parents than adoptive parents (beginning with Cloninger, 
Bohman, & Sigvardsson, 1981). 
According to recent twin studies, the genetic effect on drinking behavior may vary with 
gender, cohort, and type of measure (i.e., alcohol consumption or alcohol dependence; 
Kendler, Heath, Neale, Kessler, & Eaves, 1992; Kendler, Neale, Heath, Kessler, & Eaves, 
1994; Pickens et al., 1991). Heritability estimates also vary by age cohort (Prescott, Hewitt, 
Heath, Truett, Neale, & Eaves, 1994; Prescott, Hewitt, Truett, Heath, Neale, & Eaves, 1994). 
Separating alcohol dependence from abuse and males from females revealed the following 
consistencies (McGue, 1994): Alcohol dependence has a moderate additive genetic influ-
ence for men (40%–60%) and a modest influence for women (0%–58%). Both are affected 
by environmental factors. McGue concluded, however, that alcohol abuse (without de-
pendence) shares genetic influences with conduct disorder and other expressions of be-
havioral undercontrol, which may derive from an inability to inhibit behavior. 
Despite such high heritability estimates, it has been difficult to isolate specific genetic 
factors associated with alcoholism. Studies with genetic markers began 10 years ago. The 
first exciting results, which suggested that a major gene was linked or associated with al-
coholism, were studies with protein polymorphisms (S. Y. Hill, Aston, & Rabin, 1988; 
Tanna, Wilson, Winokur, & Elston, 1988) and a DNA polymorphism of a dopamine receptor 
(Blum et al., 1990). Subsequent results have been inconsistent, however. Many associations 
between alcoholism and protein polymorphisms have been reported but not replicated (e.g., 
Clemente, Fananas, Moral, & Sanchez-Turet, 1994; E. M. Hill, Wilson, Elston, & Winokur, 
1988; S. Y. Hill et al., 1988; Tanna et al., 1988; Wesner et al., 1991). The initial report of associ-
ation with the DRD2 marker (Blum et al., 1990) was followed by conflicting studies. These 
inconsistent results have been attributed to several possibilities; among them are the fol-
lowing: (a) Ethnicity was not matched in the affected and control samples, and (b) the A1 
allele has a nonspecific relationship to many neuropsychiatric disorders (Gelernter, Gold-
man, & Risch, 1993; McGue, 1994; Pato, Macciardi, Pato, Verga, & Kennedy, 1993). A de-
finitive analysis has recently been conducted, and it found no evidence for association of 
the A1 allele with alcoholism (Edenberg et al., 1998). 
The biological basis of vulnerability to alcoholism may eventually be clarified by two 
major long-term efforts of broad scope. One is the Collaborative Study on the Genetics of 
Alcoholism (COGA; Reich et al., 1998), and the other is an effort at the National Institute 
on Alcohol Abuse and Alcoholism Laboratory of Neurogenetics (NIAAA LN; Long et al., 
1998). The COGA study includes a multidimensional assessment for segregation and 
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linkage analyses. The NIAAA LN is conducting association and linkage studies using pop-
ulations that are genetic isolates. Both groups have published genome-wide linkage anal-
yses of an alcohol dependence phenotype (Long et al., 1998; Reich et al., 1998). Results have 
not been consistent, however. Both groups found significant linkage between locations on 
chromosome 4q and the absence of alcohol dependence, which suggests a protective effect 
of the nearby genes related to alcohol metabolism (i.e., alcohol dehydrogenase and alde-
hyde dehydrogenase). Faster alcohol metabolism might lower tolerance by causing aver-
sive flushing (Chen et al., 1996). Other linkage findings were not consistent, however. 
Significant locations on chromosomes 1 and 7 were found in the COGA study (Reich et al., 
1998), whereas a site on chromosome 11 showed linkage in the NIAAA LN study with an 
American Indian tribe (Long et al., 1998). Plausible candidate genes for alcohol dependence 
are located near these sites, including genes for neurotransmitter receptors (DRD4, a do-
pamine receptor, and GABARB1, a γ-aminobutyric acid receptor) and enzymes involved 
in neurotransmitter synthesis (tyrosine hydroxylase and tryptophan hydroxylase). 
In addition, the COGA study assessed a specific phenotype, the P3 event-related brain 
potential (Begleiter et al., 1998). For people with a variety of disorders, including alcohol-
ism, schizophrenia, and attention deficit disorder, P3 voltage is lower than normal when 
they must attend to difficult visual tasks in an experiment (reviewed by Begleiter et al., 
1998). Significant linkage was found between P3 amplitude and locations on chromosomes 
2 and 6; suggestive linkage evidence was found for locations on chromosomes 5 and 13 
(Begleiter et al., 1998). These locations do not overlap with linkage findings from the two 
studies of alcohol dependence. Future research should clarify the discrepancies in these 
findings, which could have been the result of differences in sampling and choice of phe-
notype for analysis. Achieving consistency and replicability of findings may require the 
use of very specific phenotypes. Future research must be bolstered by recent advances in 
our understanding of the phenotypic heterogeneity of alcoholism combined with current 
advances in molecular genetics. Below, we review pertinent research for both of these areas. 
Familial transmission of alcoholism has been clearly documented. The genetic determi-
nants are extremely complex, however. Different genes may influence different aspects of 
alcohol consumption, preference, and dependence; furthermore, these genes may be ex-
pressed at different developmental stages, and there is some evidence of different genetic 
mechanisms in men and women. Environmental effects on people of varying initial risk at 
various life span stages are difficult to demonstrate without clear markers of initial risk 
and clear environmental situations that are specifically tied to alcoholism. Behavior genet-
ics studies usually produce moderate heritability estimates for alcoholism (but tell nothing 
about which genes or environmental factors are critical), and proposed genetic linkages 
and associations are repeatedly unreplicated. Alcoholism needs to be treated as a complex 
trait with potential complications of incomplete penetrance, phenocopies, heterogeneity, 
or polygenic inheritance (cf. Lander & Schork, 1994). It appears that alcoholism, inclusively 
defined, will not be amenable to a search for single-gene effects; it probably is polygenic 
and heterogeneous. In reviewing the genetics literature, Stone and Gottesman (1993) con-
cluded that the most reasonable model of alcoholism is a multifactorial-polygenic one. 
Schuckit (1994) elaborated on the role of reduced responsiveness to alcohol as a risk factor 
for alcoholism within a context of a multifactorial model with potentially polygenic genetic 
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effects. In addition to focusing on polygenic models, however, other researchers are testing 
highly homogeneous subgroups with specific risks and problems to look for single im-
portant genes. There may be fewer genes involved if specific features can be examined. 
Geneticists are using methods to narrow the definition of a disease to isolate homogeneous 
subgroups that are more likely to show Mendelian inheritance (Lander & Schork, 1994; 
McGuffin, Owen, O’Donovan, Thapar, & Gottesman, 1994). Four criteria have been useful 
in medical genetics: age at onset, family history, severity, and clinical phenotype (Lander 
& Schork, 1994). Our article applies these criteria to alcoholism. The linkage and associa-
tion studies noted above treated alcoholism as a single disorder; thus, their relevance is 
unclear. Newer approaches attempt to define subtypes within the heterogeneous disorder 
of alcoholism. 
 
Homogeneous Subtypes of the Heterogeneous Alcoholism Phenotype 
 
From both phenomenological and developmental perspectives, one subtype of alcoholism 
has gained acceptance; the predominant characteristics of this subtype, called antisocial al-
coholism (AAL), are impulsive, aggressive traits (Zucker, 1987). Other subtypes are less well 
defined. Some investigators have suggested that there are several types embedded within 
the substantially more heterogeneous, nonantisocial alcoholic population (Zucker, 1994). 
One that has moderate consensus is a subtype in which depression and anxiety precede 
development of dependence; it has been labeled negative affect alcoholism (NAAL; Babor et 
al., 1992; Cloninger et al., 1981; Zucker, 1987). These two subtypes appear to be consistent 
with preclinical conditions that are differentiable among adolescents and that correlate 
with two major pathways for developing alcohol problems (i.e., an externalizing or behav-
ioral undercontrol pathway versus an internalizing pathway). Sher (1991, 1994) described 
several pathways to alcoholism, notably a deviance proneness pathway, a negative affect 
pathway, and an enhanced reinforcement pathway. The negative affect pathway appears 
to involve childhood internalizing symptomatology that—only in adulthood—may de-
velop into alcohol dependence. Women with alcoholism are more likely to show this pat-
tern than the AAL pattern (discussed further below; Schuckit, Pitts, Reich, King, & Winokur, 
1969). The typology proposed by Babor et al. (1992) was based on cluster analyses of clini-
cal characteristics. In this conceptualization, types differed on premorbid risk, age of onset, 
dependence severity, alcohol-related problems, chronicity, negative consequences, and 
comorbidity. E. O. Johnson, van den Bree, and Pickens (1996a) created symptom scales 
(“environmental” and “genetic”) that were based on differential concordance between 
monozygotic and dizygotic twins. Using cluster analysis of the scales with a sample of 
alcoholic males, they identified three subtypes: mild, severe, and dyssocial (E. O. Johnson, 
van den Bree, & Pickens, 1996b). 
AAL has been identified in multiple classifications (Babor et al., 1992; Cloninger et al., 
1981; Hesselbrock et al., 1984; Zucker, Ellis, & Fitzgerald, 1994). The hallmark characteris-
tics found in various populations are early age of onset, dense family history of alcoholism, 
greater expressivity among family members, and characteristics of adult antisocial person-
ality disorder and childhood conduct disorder (Zucker, 1994; Zucker, Ellis, Fitzgerald, & 
Bingham, 1996). E. O. Johnson, van den Bree, and Pickens (1996b) found similar symptoms 
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in two of their subtypes (severe and dyssocial). High frequency of other drug problems 
also appears to be characteristic of a subtype with antisocial traits (Helzer, Burnam, & 
McEvoy, 1991). Early elements of the AAL subtype can be differentiated even among ado-
lescents as conduct disorder symptoms (Weber, Graham, Hansen, Flay, & Johnson, 1989; 
Donovan & Jessor, 1985). Antisocial personality may be a very useful characteristic in sub-
typing for clinical treatment (Litt, Babor, Del Boca, Kadden, & Cooney, 1992). Meyer (1994) 
concluded that the AALs were a homogeneous subtype, with early age of onset of alcohol 
problems and antisocial behavior preceded by a history of childhood conduct disorder. 
Furthermore, there is evidence for significant additive genetic variance for an early age of 
onset subtype (McGue, Pickens, & Svikis, 1992). 
NAAL (Zucker, 1987) involves depression and anxiety disorders that precede the de-
velopment of alcohol problems. Longitudinal studies show such a progression in a subset 
of alcoholics (Jones, 1971). Internalizing problems and negative affect are more prevalent 
among children and adolescents who have alcoholic parents (reviewed by Sher, 1991). In-
deed, there may be some common genetic influence on major depression and alcoholism 
(Kendler, Heath, Neale, Kessel, & Eaves, 1993; Merikangas, Leckman, Prusoff, Pauls, & 
Weissman, 1985). Some anxiety disorders frequently precede alcoholism, specifically the 
cognitive anxiety disorders (e.g., agoraphobia or social phobia), but alcoholism generally 
precedes the development of other anxiety disorders such as panic disorder (Kushner, 
Sher, & Beitman, 1990; but see also a contrary argument in Schuckit & Hesselbrock, 1994). 
Researchers investigating the prominent alcoholism typologies consistently propose 
gender differences in environmental influences and in comorbidity of anxiety and depres-
sion with alcohol dependence (Babor et al., 1992; Cloninger, 1987a; Zucker, 1987). Women’s 
alcoholism is typically viewed as being secondary to other disorders, which classifies most 
alcoholic women into the NAAL subtype. However, the interrelationships of gender, 
comorbidity, and family history risk are not yet clear (Del Boca, 1994). Reports of comor-
bidity in alcoholic women do indicate more prevalent comorbid disorders than for alco-
holic men (Hesselbrock, Meyer, & Keener, 1985; Nunes, Quitkin, & Berman, 1988). Clinical 
studies of subtypes have shown a lower prevalence of AAL among women (men 50:50 and 
women 60:40, type NAAL vs. AAL; Babor et al., 1992), but Del Boca concluded that the 
phenomenology and risk factors for AAL were similar for men and for the subgroup of 
women in which it occurred. In a sample of women convicted for drunk driving, antisocial 
traits were tightly associated with early-onset alcoholism and a dense family history (Lex, 
Goldberg, Mendelson, Lawler, & Bower, 1994). Zucker and Gomberg (1995) noted that al-
coholism is tied to antisociality more tightly in women than in men. Alcohol problems are 
increasing among younger cohorts of women. In national surveys, one clear trend is a de-
creased age at onset of alcohol consumption by young women (Clayton, Voss, Robbins, & 
Skinner, 1986), and heavy drinking by young women may be more common now than in 
previous decades (Fillmore, 1984). Evidence also suggests that alcohol-related motor vehi-
cle crashes among young women have increased over the last decade (Popkin, Kannen-
berg, Lacey, & Waller, 1988). In the past, cultural sanctions against drinking by women 
may have masked the role of biological susceptibility in patterns of alcoholism. Thus, ef-
forts to study the AAL subtype in women are warranted. 
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The AAL subtype shows a stronger transmission pattern than alcoholism broadly de-
fined. As a rough estimate, approximately 20% of men and 5% of women in the general 
population meet criteria for alcohol abuse (Reich & Cloninger, 1990). First-degree relatives 
of alcoholics have a two- or three-fold greater risk of alcoholism (about 45% for male rela-
tives, 15% for female relatives) than relatives of nonalcoholics (Reich & Cloninger, 1990). 
Estimates from Guze, Cloninger, Martin, and Clayton (1986) were similar; they found the 
risk for male relatives of alcoholics to be 27.2%, compared with 16.8% for male relatives of 
nonalcoholics (figures for women: relatives of alcoholics, 6.1% vs. relatives of nonalcohol-
ics, 2.3%). Although the AAL subtype is less prevalent (about one fourth to one third of 
alcoholics), family transmission is stronger. The original studies (reviewed in Cloninger, 
1987a) gave relative risks for men from NAAL fathers of about 2 to 1 (9% vs. 4%), compared 
with relative risks of 6.9 for those with AAL fathers (about 2.5% vs. 17.2%). Whereas Clon-
inger’s (1987b) typology and the specific adoption studies providing evidence for it have 
been heavily criticized (Searles & Alterman, 1994), there has been little argument that al-
coholics with the defining criteria (early onset and antisocial traits) also come from families 
more densely loaded with alcoholism vulnerability. Thus, AAL is a promising subtype for 
genetic analysis, meeting Lander and Schork’s (1994) criteria of early age at onset, dense 
family history, and restricted phenotype. 
 
Relationship of Specific Features of AAL to Serotonin 
 
There are hallmark features of the AAL subtype that are related to biochemical findings. 
We will focus on impulsivity, a dimension that may underlie the manifestations of alco-
holism, antisociality, and aggression that characterize people with AAL. McGue (1994) 
considered behavioral undercontrol disorders to be the basis of genetic influences on male 
alcohol abuse. Behavioral undercontrol is related to impulsiveness and aggression. The 
serotonin system has a clear relationship to impulsivity. In Virkkunen and Linnoila’s 
(1993) model of serotonin effects on drinking, they specified a relationship between sero-
tonin and impulsivity that may lead to drinking, which may in turn lead to release of previ-
ously inhibited aggression. Sher (1994) cautioned, however, that links between impulsivity 
and drinking are not proven; rather, he suggested the related construct of coping skills or 
problem solving to be a more general deficit among alcoholics. The most accepted model 
of the role of intoxication in releasing aggression is disinhibition (Bushman & Cooper, 
1990; Graham, 1980). According to this model, the effect of alcohol probably operates by 
reducing fear and decreasing cognitive ability to plan (Pihl, Peterson, & Lau, 1993). In 
Cloninger’s far-reaching biosocial model of personality, the serotonin system is related to 
a harm avoidance dimension (Cloninger, 1986,1987a, 1987b). Cloninger’s (1987b) definition 
of harm avoidance was “a heritable tendency to respond intensely to signals of aversive 
stimuli, thereby learning to inhibit behavior to avoid punishment, novelty, and frustrative 
nonreward” (p. 575). He characterized the antisocial personality type (Type II alcoholic) as 
having the following traits: high novelty seeking, low harm avoidance, and low reward 
dependence. The combination of high novelty seeking and low harm avoidance was hy-
pothesized to be common to the “impulsive-aggressive” personality cluster. Our 
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conceptualization is also that a salient feature of AAL is impulsivity, which may be synon-
ymous with low harm avoidance. 
This interpretation basically fits the model presented by Benkelfat (1993), who depicted 
serotonin as affecting behavioral modulation in general, where the result of low serotonin 
level varies depending on the behavioral dimension that is activated at a particular time 
(p. 54). For example, regarding the dimension of consummatory behavior, the typical out-
put is feeding, but the output when serotonin levels are low is hyperphagia. For aggressive 
behavior, the output is hostility or fighting, which is potentiated when serotonin is low. In 
a similar manner, in the context of reward, the dimension of operant behavior has an out-
put of self-stimulation, which may be facilitated by low serotonin. Siever and Trestman 
(1993) viewed low serotonin effects as a release from suppression of punished behavior 
(i.e., impulsivity). Jacob and Fornal (1994) conceptualized serotonin’s actions similarly, as 
modulating and integrating both motor output and sensory input. Disruption of this func-
tion could result in abnormal reactivity to stimuli as well as inappropriate repetitive be-
haviors (e.g., consumption or aggression). Anton (1996) presented a model of the neural 
basis of various facets of alcoholism in which he postulated that serotonin plays a role in 
“craving,” obsessional thinking, and compulsive use, in contrast with other facets of alco-
holism that are subserved by dopamine (sensitization), endorphin-enkaphalin (reward 
sensation), or norepinephrine and γ-aminobutyric acid (stress reduction; p. 44). Compul-
sive use is within the realm of the dimension we focused on in AAL—behavioral undercon-
trol and impulsivity. 
 
Serotonergic Neurotransmission in AAL 
 
LeMarquand, Pihl, and Benkelfat (1994a, 1994b) recently reviewed the relevant evidence 
for a role of serotonergic neurotransmission in alcohol intake, abuse, and dependence. The 
potential involvement of components of the serotonin system is shown in Table 1. In this 
table, we note the existence and type of evidence relating to deficits in particular compo-
nents. If more than two studies support a relationship, these are given in the text rather 
than tabulated (i.e., “see text”). Receptors are described using the nomenclature estab-
lished in 1993 by the Serotonin Club Receptor Nomenclature Committee (Humphrey, Har-
tig, & Hoyer, 1993). There is conflicting evidence in many areas because of small sample 
sizes and the use of differing methodologies. The information in Table 1 is presented for 
heuristic purposes, and it indicates whether evidence exists from animal and human 
experimental studies for an association of a change in a component with alcohol consump-
tion or alcoholism. Studies of genetic polymorphism or deletions are described and tabu-
lated later. Results from clinical trials with alcoholic patients are also discussed and 
tabulated in a later section. Experimental studies are described for rodents, nonhuman pri-
mates, and then humans. 
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Table 1. Potential Involvement of Serotonergic Neurotransmission in Antisocial Alcoholism 
Component Functional relationship Sample Reference 
Synthesis    
   Tryptophan hydroxylase See Table 2  See Table 2 
Serotonin level Lower level assoc. 
   w/ consumption 
Rodents See text 
Metabolism    
   5-HIAA Lower levels assoc. 
   w/ alcohol consumption 
Rhesus macaques Higley et al., 1996a 
 Lower levels assoc. 
   w/ lower social dominance 
Rhesus macaques Higley etal., 1996b 
 Lower levels assoc. w/ 
   impulsivity and aggression 
Rhesus macaques Mehlman et al., 1994 
 Lower level in groups 
   with AAL 
Multiple groups See text 
 Lower levels assoc. 
   w/ aggression 
Obs.-comp. 
   patients 
Insel et al., 1990 
 Lower levels assoc. 
   w/ suicidality 
Alc.-dep. patients Roy et al., 1990 
 Lower levels assoc. 
   w/ impulsivity  
Alc.-dep. viol. 
   offenders 
Virkkunen et al., 1994 
 Lower levels assoc. 
   w/ family history of AAL 
Viol, offenders Virkkunen et al., 1996 
Activity    
   Autoreceptors    
      1A Higher density of receptors 
   in cortex 
P rats See text 
 Antagonists reduce alcohol 
   drinking 
P rats Zhou et al., 1998 
 Agonists block aggression Male mice Sanchez et al., 1993 
      1B (alias 5-HT1Dβ) See Table 2  See Table 2 
      1E, 1F No evidence of relationship  No studies 
   Postsynaptic receptors    
      2A (alias 5-HT2) Lower receptor density 
   in brain 
P rats McBride et al., 1993 
 Mixed results of antagonist 
   on consumption 
Rodents See text 
 Reduced binding in platelets Violent adol. 
   patients 
Blumensohn et al., 
   1995 
 Antagonist ritanserin had 
   no effect on intoxication 
Healthy volunteers Estevez et al., 1995 
      2B No evidence of relationship  No studies 
      2C (formerly 5-HT1C) Responses blunted among 
   alcoholics especially AAL for 
   agonists MK-212 and m-CPP 
Alc.-dep. patients Handelsman et al., 
   1996 
George et al., 1997 
      3 Antagonists fail to reduce 
   ethanal self-admin. 
Long-Evans rats Beardsley et al., 1994 
 Antagonist ondonsetron 
   increased subjective 
   intoxication 
Healthy volunteers Swift et al., 1996 
      4 Antagonist GR 113808 reduces 
   ethanol self-admin. 
P rats Panocka et al., 1995 
      5A, 5B, 6, 7 No evidence of relationship  No studies available 
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Table 1. continued 
Component Functional relationship Sample Reference 
Reuptake    
   Serotonin transporter Uptake inhibitors decrease 
   drinking 
Rodents See text 
 Uptake higher in alcoholics 
   and their adult children 
Alcoholic patients See text 
 Platelet imipramine binding 
   correlated with hostility 
Mixed patients Same et al., 1995 
 More platelet transporter sites 
   in aggressive group 
Pers. dis. patients Coccaro et al., 1996 
   Transporter promoter See Table 2   
Metabolism    
   Monoamine oxidase A See Table 2  See Table 2 
   Monoamine oxidase B Low platelet activity assoc. 
   w/ AAL subtype 
Alcoholic patients See text 
Note: Assoc. = associated, admin. = administration, AAL = antisocial alcoholism, alc.-dep. = alcohol-dependent, 
obs.-comp. = obsessive-compulsive, viol. = violent, P = alcohol-preferring, adol. = adolescent, pers. dis. = per-
sonality disorder 
 
There is a large body of animal and experimental literature suggesting that increases 
and decreases in serotonin function inversely affect ethanol consumption (LeMarquand et 
al., 1994b). There is more support for the proposal that increases in serotonin (5-HT) trans-
mission are associated with decreases in intake of ethanol but less support for the converse, 
that decreased 5-HT leads to increased drinking (LeMarquand et al., 1994b). In this section, 
we will discuss relevant animal research and then describe human studies. In animals, 
ethanol intake has been shown to decrease after administration of 5-HT precursors, 5-HT 
uptake inhibitors, intracerebral 5-HT, and postsynaptic 5-HT agonists (Naranjo & Bremner, 
1993). 
Strains of alcohol-preferring rats (P; nonpreferring = NP) showed lower central 5-HT; 
this finding was true for both the P strain (J. M. Murphy, McBride, Lumeng, & Li, 1982) 
and fawn-hooded rats (Rezvani, Overstreet, & Janowsky, 1990). In F2 generation rats of 
P × NP intercrosses, both 5-HT and its metabolite, 5-hydroxyindoleaceticacid (5-HLAA), 
were lower in the nucleus accumbens of high-intake than in low-intake animals, confirm-
ing an association between alcohol-drinking behavior and the serotonin system in the P 
and NP strains (McBride, Bodart, Lumeng, & Li, 1995). There is some evidence that P rats 
differ in 5-HT transporter function, as reflected by imipramine binding and serotonin up-
take (Aurora, Tong, Jackman, Staff, & Meltzer, 1983). Selective serotonin reuptake inhibi-
tors (SSRIs) also affect the transporter, and they clearly decrease drinking in P rats (J. M. 
Murphy et al., 1988; Rezvani et al., 1990). Furthermore, in P strains of rats, high alcohol-
seeking behavior correlated with higher density of 5-HT1A receptors in the cortex (McBride, 
Guan, Chernet, Lumeng, & Li, 1994; Wong, Reid, Li, & Lumeng, 1993; Wong, Threlkeld, 
Lumeng, & Li, 1990). Selectively blocking 5-HT1A receptor activity caused significant re-
duction in alcohol consumption by P rats, and combined SSRI and antagonist treatment 
reduced drinking further (Zhou, McKinzie, Patel, Lumeng, & Li, 1998). A recent study with 
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P rats showed reduction of alcohol intake after treatment with a 5-HT4 antagonist 
(Panocka, Ciccocioppo, Polidori, Pompei, & Massi, 1995). 
The specific 5-HT receptor subtypes appear to have a role in rodents’ aggressive behav-
ior, along with their role in alcohol consumption (Sanchez, Amt, Hyttel, & Moltzen, 1993). 
The co-occurrence of serotonergic effects on alcohol consumption and aggression will be 
noted below in studies with nonhuman primates and humans. Both behavior patterns may 
be affected by alterations in the general dimension of impulsivity, as described earlier. 
A program of research with primates has begun at the National Institutes of Health; 
this program is using rhesus macaques as a model of aggression, alcohol consumption, 
and impulse control (Mehlman et al., 1994). Cerebrospinal fluid (CSF) 5-HIAA has been 
inversely correlated with instances of intense aggression and with an operational measure 
of impulsive risk taking (e.g., comparatively long leaps through forest canopy; Mehlman 
et al., 1994). A confirmatory study from another laboratory showed individual differences 
among male cynomolgus monkeys (also macaques) in hormonal response to fenfluramine; 
monkeys with blunted response showed more aggressive behavior (Keyes, Botchin, Kaplan, 
Manuck, & Mann, 1995). Young male rhesus macaques that were raised by peers exhibited 
lower CSF 5-HIAA than those raised by their mothers (Higley, Suomi, & Linnoila, 1996a). 
In the same study, young male macaques with low CSF 5-HIAA and those less competent 
in social behaviors consumed more alcohol than monkeys with high CSF 5-HIAA or those 
that were more socially competent. In a companion article, Higley, Suomi, and Linnoila 
(1996b) reported that low CSF 5-HIAA was associated with low social dominance (measured 
by tests in which animals competed for food). To assess the impact of CSF 5-HIAA differ-
ences in survival to adulthood, Higley, Mehlman, et al. (1996) monitored 49 free-ranging 
macaques over 4 years and found low CSF 5-HIAA to be a robust predictor of aggression 
and premature death. 
Reviewing clinical research related to alcohol, LeMarquand et al. (1994a) concluded 
that lowered central serotonin neurotransmission appears to be associated with alcoholism 
among some but not all samples. The AAL subtype may be specifically associated with 
lower serotonin function. Most studies to date have not separated subtypes for biological 
studies. Even so, evidence is accumulating that AAL might be associated with preexisting 
low serotonin activity (first proposed by Ballenger, Goodwin, Major, & Brown, 1979). 
CSF 5-HIAA measures on patients with early onset or antisocial characteristics (i.e., 
AAL) or both have consistently been lower than for nonalcoholic community samples or 
NAAL patients (Ballenger et al., 1979; Fils-Aime et al., 1996; Roy & Linnoila, 1989; Roy, 
Virkkunen, & Linnoila, 1987), which is interpreted as reduced central serotonin turnover 
(Roy et al., 1987). Furthermore, this finding has been repeated in comparisons of sons of 
antisocial alcoholics with sons of nonantisocial alcoholics (Virkkunen, Eggert, Rawlings, & 
Linnoila, 1996; Virkkunen & Linnoila, 1993). Associations have been reported between low 
CSF 5-HIAA and lifetime aggression scores (Limson et al., 1991). Virkkunen and Linnoila 
concluded that testosterone affects outward-directed aggression, whereas low 5-HIAA is 
related to impulsiveness. 
Serotonergic responsivity in the limbic system and hypothalamus is tested by single-dose 
challenges with direct or indirect-acting serotonin agonists (D. L. Murphy, Mueller, Garrick, 
& Aulakh, 1986; D. L. Murphy, 1990). Lee and Meltzer (1991) found alcoholic men to have 
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a decreased pituitary response to the 5-HT precursor, L-5-hydroxytryptophan (L-5-HTP), 
and to the 5-HT2C receptor agonist, MK-212, compared with normal controls. The serotonin 
releasing agent, fenfluramine, also serves as a challenge that generally produces a large 
prolactin increase; blunted response to this agent in a sample of patients with personality 
disorder but not alcoholism nor antisocial traits has been associated with family history of 
impulsive aggression (Coccaro, Kavoussi, Sheline, Lish, & Csernansky, 1996). 
Several experimental studies have involved administration of the 5-HT2C receptor ago-
nist m-chlorophenylpiperazine (m-CPP) to abstinent alcoholics, resulting in subjective alcohol-
like effects, alcohol craving, and blunted neuroendocrine responses (Benkelfat et al., 1991; 
Krystal, Webb, Cooney, Kranzler, & Charney, 1994). Cortisol responses to m-CPP in detox-
ified alcoholics were also blunted, which may reflect reduced 5-HT2C receptor function 
(Krystal et al., 1996; George et al., 1997). Prolactin responses to m-CPP were similarly 
blunted in subjects with antisocial personality disorder and substance abuse (Moss, Yao, 
& Panzak, 1990). In another study with abstinent alcoholics, prolactin response to m-CPP 
was inversely correlated with trait measures of irritability and depression, although there 
was no significant blunting on average for the heterogeneous sample tested. Buydens-
Branchey, Branchey, Ferguson, Hudson, and McKernin (1997) reported that m-CPP de-
creased craving for alcohol and intensified a “high” feeling in alcoholics but not in healthy 
control subjects. New studies with subtypes of alcoholics revealed distinct subjective re-
sponses to m-CPP (George et al., 1997); AAL-type subjects (early onset and antisocial traits) 
reported euphoria, whereas NAAL-type subjects reported anxiety. The authors interpret 
the differential response as m-CPP’s facilitation of the expression of preexisting symptoms 
rather than the induction of emotion by m-CPP (George et al., 1997). There is justification 
for further investigations of the relationships among preexisting hostility, alcoholism ty-
pology, and subjective response to agents affecting 5-HT2C receptor function. A more spe-
cific agent than m-CPP might yield clearer experimental results because m-CPP is also an 
antagonist of 5-HT3 and 5-HT2A receptors, in addition to having a high affinity for 5-HT2C 
receptors (Roth, 1994). 
In two other experimental studies, researchers examined subjective responses to alcohol 
that had been combined with agents that affect serotonin receptors. No effects on subjec-
tive alcohol intoxication were shown for a 5-HT2A antagonist, ritanserin (Estevez, Parrillo, 
Giusti, & Monti, 1995). The sample size was small (N = 12), however; the only detectable 
effect of ritanserin was on fatigue (i.e., levels of tiredness and alertness). Ondonsetron, a 
5-HT3 antagonist, affected subjective intoxication in a similar experiment (N = 12) that used 
a slightly higher alcohol dose (Swift, Davidson, Whelihan, & Kuznetsov, 1996; 0.65g/kg vs. 
0.5g/kg in Estevez et al., 1995). Ondonsetron increased both the sedative and impairing 
effects and the stimulant effects of alcohol; subjects reported feeling more intoxicated dur-
ing the ondonsetron than the placebo session (Swift et al., 1996). Earlier studies with lower 
doses of alcohol and ondonsetron had shown no effect on subjective response to alcohol 
(Doty, Zacny, & deWit, 1994) nor a reduction in positive moods measured by visual analog 
scales (B. A. Johnson, Campling, Griffiths, & Cowen, 1993). Further studies with a standard 
experimental design are warranted to understand these conflicting results. 
AAL patients appear to have more active reuptake of serotonin from the synapse. Ser-
otonin uptake was higher in blood platelets from alcoholics and former alcoholics than 
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healthy controls (Boismare et al., 1987). In fact, serotonin uptake in platelets has been 
shown to be higher in a group of individuals with alcoholic fathers than in a control group 
(Ernouf et al., 1993; Meltzer & Arora, 1988). Results are not consistent across patient 
groups, however. Same et al. (1995) found a positive correlation between imipramine bind-
ing to platelets (a measure of 5-HT transporter action) and hostility (in samples of schizo-
phrenics and criminal offenders but not normal controls), whereas Coccaro et al. (1996) 
found a negative association between the number of platelet 5-HT transporter sites and a 
life history of aggressive behavior in patients with personality disorder but not normal 
controls. 
The AAL subtype may be associated with reduced monoamine oxidase (MAO) activity. 
Results that seemed inconsistent at first appear to be more consistent when groups are 
subdivided by typology. Initial studies were conflicting about whether MAO activity is 
reduced in alcoholics (positive findings; Lykouras, Markianos, & Moussas, 1989; Sullivan, 
Stanfield, Schanberg, & Cavenar, 1978; Wieberg, Gottfries, & Oreland, 1977; negative find-
ings: Tabakoff et al., 1988; von Knorring, Bohman, von Knorring, & Oreland, 1985). When 
alcoholics were subdivided according to onset or other AAL features, reduced MAO ac-
tivity was found more consistently (Sherif, Hallman, & Oreland, 1992; von Knorring et al., 
1985). Platelet MAO activity was about one standard deviation lower in Type II alcoholic 
patients (early onset with violence, arrests, or other substance abuse but not necessarily 
antisocial personality disorder) compared with Type I patients (Hallman, von Knorring, & 
Oreland, 1996). 
Thus, results from current physiological literature support a deficit in 5-HT function 
among antisocial alcoholics, but there is not sufficient converging evidence directed to a 
specific dysfunctional component. A complete scan of all components will be required to 
uncover the primary underlying deficit; one primary deficit could cause apparent differ-
ences in many components resulting from adaptation or compensation by other parts of 
the system. Integrating the relevant findings is made more complicated by paradoxical 
effects, such as associations of lower MAO, which degrades serotonin, with the same re-
sponses that are associated with lower serotonin. Kranzler and Anton (1994) interpreted 
m-CPP challenge findings as indicating that alcoholics may have low 5-HT synthesis, 
which would lead to up-regulation of receptors, which would then be abnormally sensitive 
to agonists. Similarly, 5-HT1A agonists produce complex results, probably because this 
receptor type is both an autoreceptor (i.e., presynaptic) and a postsynaptic receptor (Ben-
kelfat, 1993). As another example, lowered 5-HIAA could result from decreased 5-HT syn-
thesis and thus would be associated with less transmission, or lower 5-HIAA could result 
from decreased degradation, which would be associated with more transmission. 
The likelihood that there are genetic lesions in all these components is minuscule. Ra-
ther, it is likely that there is a primary abnormality, and other dysregulation results from 
functional alterations by serotonin neurons to compensate for one primary deficit. By ex-
amining multiple markers in the serotonin pathway, researchers are more likely to uncover 
a deficit that is primary. Current studies will necessarily be limited by the feasibility of 
studying particular markers; a review of available polymorphisms follows. 
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Serotonin-Related Genetic Polymorphisms and AAL 
 
Genetic markers have become available for characterizing important components of sero-
tonin synthesis and metabolism. Table 2 lists known markers and evidence for functional 
significance. Genetic studies are cited; functional evidence from Table 1 is noted where no 
genetic studies are available. Markers are located on autosomal and X chromosomes (au-
tosomal: TPH, HTR1A, HTR1B, HTR2A, HTR3, SLC6A4, HTTLPR; and X: HTR2C, MAOA, 
MAOB). Animal research will be noted, and then molecular genetic studies with humans 
will be described. 
 
Table 2. Promising Serotonin Candidate Genes for Antisocial Alcoholism (AAL) 
Component Chrom. Genea Genetic associationb Sample Reference 
Synthesis      
   Tryptophan 
      hydroxylase 
11p15 + TPH Assoc. w/ suicidality AAL patients Nielsen et al., 
   1994 
Activity      
   5-HT1A receptor 5q11-q13 + HTR1A See Table 1   
   5-HT1B receptor 
      (in humans 
       5-HT1Dβ) 
6q13 + HTR1B Deletion in mouse 
    aggression 
Knock-out mice Saudou et al., 
   1994 
   Deletion in mouse 
    more drinking 
Knock-out mice Crabbe et al., 
   1996 
   Assoc. w/ antisocial 
   alcoholism 
   diagnosis 
Navaho and 
   Finnish 
   families 
Lappalainen 
   et al., 1998 
   5-HT2A receptor 
      (previously 
       5-HT2) 
13q14-q21 + HTR2A See Table 1   
   5-HT2C receptor 
      (previously 
       5-HT1C) 
Xq24 + HTR2C Prelim. marker assoc. 
   w/ alcoholism 
Finnish 
   families 
Goldman, 1995 
   Prelim. marker assoc. 
   w/ TPQ persistence 
   and reward 
   dependence 
Mixed 
   volunteers 
Ebstein et al.,  
   1997 
   5-HT3 receptor 11q23 – HTR3 See Table 1   
Reuptake      
   Serotonin 
      transporter 
17q11-q12 + SLC6A4 See Table 1   
   Transporter 
      promoter 
17q12 + HTTLPR Assoc. w/ TPQ 
   harm avoidance 
Mixed 
   volunteers 
Lesch et al, 1996 
   Assoc. w/ severe 
   alcohol dependence 
Alc.-dep./ 
   severe 
   withdrawal 
Sander et al., 
   1997 
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Table 2. continued 
Component Chrom. Genea Genetic associationb Sample Reference 
Metabolism      
   Monoamine 
      oxidase A 
Xp11 + MAOA Deletion in mouse 
    aggression 
C3H transgenic 
   mice 
Cases et al., 
   1995 
   Deletion assoc. w/ 
   Brunner syndrome 
Dutch families Brunner et al., 
   1993 
   Prelim. marker assoc. 
   w/ early-onset 
   alcoholism 
Adol. sub. ab. 
patients 
Vayukov et al., 
   1995 
   Monoamine 
      oxidase B 
Xp11 + MAOB See Table 1   
Note: Chrom. = chromosome, assoc. = associated, prelim. = preliminary, alc.-dep. = alcohol-dependent, TPQ = 
Tridimensional Personality Questionnaire, adol. = adolescent, sub. ab. = substance abuse 
aGenes with reported polymorphisms are shown with a +. 
bDetails are given for molecular genetic studies; “see Table 1” is noted where functional evidence refers to the 
physiological work previously listed in Table 1. 
 
Genetic markers for several receptors have been studied. An exciting recent finding 
implicates the 5-HT1B receptor. Null mutant mice lacking the gene for this receptor drank 
twice as much alcohol as wild mice and also showed less sensitivity to alcohol’s ataxic 
effects (Crabbe et al., 1996). The 5-HT1B receptor gene has been implicated in studies map-
ping quantitative trait loci that are associated with differences in drinking behavior or re-
sponse to alcohol (Phillips, Crabbe, Metten, & Belknap, 1994). Mice with an experimental 
deletion of the gene for the 5-HT1B receptor show high levels of aggression (Saudou et al., 
1994). The coupling of aggression with alcohol consumption is again seen with animal ge-
netic research. One marker related to reuptake has been studied in a “knock-out” mouse 
strain with a deletion of MAOA; this experimental animal is abnormally aggressive (Cases 
et al., 1995). 
Molecular genetic studies with humans have involved markers related to synthesis, ac-
tivity, and reuptake and have included clinical samples with alcoholism, violence disor-
ders, or both, and community samples with varying levels of impulsive personality traits. 
At the NIAAA LN, an intensive initiative is underway to examine linkage of alcoholism to 
serotonin markers (Goldman, 1995). The gene for tryptophan hydroxylase (TPH), which 
codes for the rate-limiting enzyme in the biosynthesis of serotonin, has been isolated (Niel-
sen, Dean, & Goldman, 1992; Stoll & Goldman, 1991). One of the two TPH alleles was as-
sociated with CSF 5-HIAA concentration and a history of suicide attempts in a subgroup 
of impulsive, alcoholic, violent offenders. Although no TPH allele association was found 
when categories of impulsive and nonimpulsive offenders were compared, the use of 
standardized measures of impulsivity may better detect an association (Nielsen et al., 1994). 
Abbar et al. (1995), however, did not find an association between TPH and a history of 
suicide attempts; they did not attempt to measure impulsivity. The TPH polymorphism is 
probably not functionally significant because it is located in an intron (Nielsen et al., 1994). 
Rather, it may be in disequilibrium to a variant that does affect activity of TPH (Nielsen et 
al., 1994). Tryptophan oxygenase, a marker for which is located on 4q31, has been sug-
gested as a candidate gene for alcoholism because it converts L-tryptophan to kynurenine, 
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reducing tryptophan availability (Comings, Muhleman, Dietz, & Donlon, 1991). This enzyme 
has not been studied in alcoholic patients, however, and will not be discussed further. 
Several genes related to serotonin receptors have been tested in association studies. Poly-
morphisms have been published for the gene for the 5-HT1A receptor (HTR1A; Warren, 
Peacock, & Fink, 1992), but no studies with alcoholism have been performed. The gene for 
the human receptor 5-HT1B/5-HT1Dβ (identical according to Hamblin, McGuffin, Metcalf, 
Dorsa, & Merchant, 1992) is listed as HTR1B. Researchers at the NIAAA LN reported an 
association with antisocial alcoholism of a silent polymorphism in HTR1B (Lappalainen et 
al., 1998; Lappalainen, Dean, et al., 1995). The sample comprised southwestern Indians and 
Finnish patients with antisocial alcoholism. The 5-HT2A receptor gene (HTR2A; Sparkes 
et al., 1991) has been linked closely to esterase D (Hsieh et al., 1990), but no molecular 
genetic studies with alcoholism have been reported. The gene for the 5-HT3 receptor has 
recently been localized (Weiss, Mertz, Schrock, Koenen, & Rappold, 1995), but no poly-
morphism has been described. Once a polymorphism has been reported, it will be a prom-
ising marker to test, especially among NAAL patients, because anxiety and depression are 
common in this subgroup. In a study of NAAL-type Finnish patients, a preliminary asso-
ciation with alcoholism was reported, with the 5-HT2C Cys23-Ser23 variant (HTR2C; Gold-
man et al., 1995; Lappalainen, Zhang, et al., 1995). It is interesting to note that this marker 
showed some evidence of association with the personality measures of persistence and 
reward dependence when polymorphisms were tested jointly for HTR2C and two dopa-
mine receptor markers (Ebstein et al., 1997). No association with harm avoidance was 
found, but sample sizes were small for the less frequent 2ser allele. 
Related to reuptake, the gene for the serotonin transporter, SLC6A4, has been cloned 
(Blakely et al., 1991; Hoffman, Mezey, & Brownstein, 1991). In addition, a marker for the 
regulatory region that modulates transcription has been localized nearby (HTTLPR; Lesch 
et al., 1996). Association studies with this marker among individuals and sibships show a 
small but significant contribution to variance in anxiety-related traits, as measured by per-
sonality scales (Lesch et al., 1996). One of these was a subscale of the Tridimensional Per-
sonality Questionnaire, Harm Avoidance, which is related to Cloninger’s concept of the 
impulsive-aggressive personality cluster as having low harm avoidance (Cloninger, 1987b). 
Recently, the “short” variant of the promoter (HTTLPR) showed association with a narrow 
clinical phenotype, a subgroup of alcoholic patients who experienced severe withdrawal 
symptoms compared with a control group (Sander et al., 1997). MAOA and MAOB are 
tightly linked on the X chromosome (Harris, Kurth, Barnes, Bowcock, & Kurth, 1993; Ho-
tamisligil & Breakefield, 1991). Although it is responsible for platelet MAO activity, a com-
plete deficiency of MAOB may not interfere with 5-HT metabolism, however (Lenders et 
al., 1997). A null mutation in the MAOA gene has been linked to impulsive violence in an 
extended family with male members prone to aggressive, violent outbursts (Brunner, 
Nelen, Breakefield, Ropers, & van Oost, 1993). Alcoholism did not co-occur with these out-
bursts, however. One MAOA polymorphism has been examined in patients with early on-
set substance abuse (Vanyukov, Moss, Yu, Tarter, & Deka, 1995). The long repeat allele of 
a dinucleotide repeat-length polymorphism was associated in young men but not young 
women. Conduct disorder symptoms were not specified in these young people (mean age 
was 15 years). 
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Thus, several recent findings are highly suggestive of associations between alcoholism, 
impulsivity, aggression, and components of serotonin neurotransmission. Particularly prom-
ising are the receptor markers HTR1B and HTR2C, along with markers for synthesis and 
reuptake components. None of these preliminary associations have been confirmed using 
families or methods that are conclusive, such as the haplotype relative risk method, which 
prevents confounding by ethnic differences between control and affected groups (see be-
low). All genes listed in Table 2 should be studied. However, no polymorphism has been 
reported so far for HTR3 and HTR4. If certain components of the serotonin system can be 
shown to be implicated in conferring vulnerability to AAL, then those components are 
logical target sites for pharmacotherapy. 
 
Serotonergic Pharmacotherapy in AAL 
 
Recent advances in the pharmacotherapy of alcoholism were reviewed in detail by Litten, 
Allen, and Fertig (1996) and Schuckit (1996). Pettinati (1996) reviewed research specifically 
related to serotonergic agents. Clinical trials have been conducted or are in progress with 
several classes of drugs. For almost 50 years, the only medication approved for alcoholism 
treatment by the U.S. Food and Drug Administration was disulfiram (Antabuse), an aver-
sive therapy that, when combined with alcohol, produces headache, nausea, respiratory 
problems, and palpitations. It is used effectively as an adjunct treatment to psychosocial 
therapy in a monitored setting (Fuller et al., 1986). The only other medication to be ap-
proved for use in alcoholism treatment is naltrexone, an opioid antagonist. Recent trials 
have shown naltrexone to reduce alcohol craving and consumption among male patients 
(O’Malley et al., 1992; Volpicelli, Alterman, Hayashida, & O’Brien, 1992). Acamprosate 
(calcium acetylhomotaurinate) has shown significant effects on relapse rates and consump-
tion frequency in clinical trials in Europe (Whitworth et al., 1996); the mechanism of action 
is unclear. Recent neuroscience research has implicated dopamine, opioids, and serotonin, 
all acting in areas of the limbic system, as underlying alcohol preference (Hunt, 1993). 
These neurotransmitter systems may be arenas for future pharmacology development. It 
is unknown whether the alcoholism subtypes discussed above would show differential 
response to naltrexone; laboratory studies with social drinkers have provided some evi-
dence that alcoholism family history may affect response to naltrexone with alcohol (King, 
Volpicelli, Frazer, & O’Brien, 1997). Gerra et al. (1992) conducted a crossover trial of fluox-
etine and acamprosate and analyzed the results by patients’ family history. Subjects with 
a family history of alcoholism responded better to fluoxetine than acamprosate and vice 
versa. Subtyping of alcoholics becomes more interesting as more details are known about 
interactions of these neurotransmitter systems. 
Potential alcoholism treatment medications have been tested specifically to ameliorate 
5-HT dysregulation (see Pettinati, 1996, for a recent review). Table 3 summarizes the med-
ications that affect serotonin system components discussed above. Some components do 
not have commercially available agents. Other components, which are affected by familiar 
agents (e.g., MAO inhibitors), have not been tested in clinical trials with alcoholic patients. 
Nor should they necessarily be tested, particularly agents with broad effects, such as MAO 
inhibitors and SSRIs. Negative clinical trials have been reported with administration of the 
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precursor to serotonin, tryptophan (George et al., 1992). Table 3 summarizes which agents 
affect which components of the 5-HT system. It is not at all clear that each agent listed 
would have a beneficial effect. 
 
Table 3. Clinical Trials Relevant to Serotonin System Components and Antisocial Alcoholism 
Component Genea Pharmacotherapy Clinical efficacy Sample Reference 
Synthesis      
   Tryptophan 
      hydroxylase 
+ TPH Tryptophan Negative Alc.-dep. 
   patients 
George et al., 
   1992 
Activity      
   5-HT1A receptor + HTR1A Buspirone 
   (partial agoninst) 
Positive Anx./alc. 
   patients 
Tollefson et al., 
   1992 
Kranzler et al., 
   1994 
   Negative Anx./alc. 
   patients 
Malcolm et al., 
   1992 
   5-HT1B receptor 
      (in humans 
       5-HT1Dβ) 
+ HTR1B None None   
   5-HT2A receptor 
      (previously 
       5-HT2) 
+ HTR2A Ritanserin 
   (antagonist) 
Mildly positive Alc.-dep. 
   patients 
Monti and Al- 
  terwain, 1991 
   Negative Heavy 
   drinkers 
Naranjo, Pou- 
  los, et al., 1995 
   Negative   
   Negative Alc.-dep. 
   patients 
B. A. Johnson, 
   Jasinski, et 
   al., 1996 
   5-HT2C receptor 
      (previously 
       5-HT1C) 
+ HTR2C m-CPP; MK-212 
   (agonists) 
None   
   5-HT3 receptor – HTR3 Ondonsetron 
   (antagonist) 
Some reduction 
   of intake 
Alc.-dep. 
   patients 
Sellers et al., 
   1994 
Reuptake      
   Serotonin 
      transporter 
+ SLC6A4 SSRIsb Positive Alc.-dep. 
   patients 
Tiihonen et al., 
   1996 
   Transporter 
      promoter 
+ HTTLPR  Negative Alc.-dep. 
   patients 
Kabel and 
   Petty, 1996 
   See text for pre- 
   1995 studies 
  
Metabolism      
   Monoamine 
      oxidase A 
+ MAOA None None   
   Monoamine 
      oxidase B 
+ MAOB MAO inhibitors None   
Note: SSRIs = selective serotonin reuptake inhibitors, alc.-dep. = alcohol-dependent, anx./alc. = anxiety/alco-
holism 
aGenes with reported polymorphisms are shown with a +. 
bFor example, fluoxetine, zimelidine, citalopram, viqualine, sertraline, paroxetine. 
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The most extensive research has used the class of antidepressant agents that selectively 
inhibit SSRIs, which includes fluoxetine, zimelidine, citalopram, viqualine, sertraline, and 
paroxetine. Even though multiple studies have been conducted, a clear pattern of results 
has not emerged (Litten et al., 1996; Pettinati, 1996). Results are not consistent when patient 
groups are subdivided by alcoholism severity, by type of medication, nor by definition of 
relapse. Early studies showed positive results for samples with alcohol problems (vari-
ously defined as alcohol abusers or heavy drinkers; Gatto, Murphy, McBride, Lumeng, & 
Li, 1990; Gorelick, 1989; Naranjo & Sellers, 1989; Naranjo et al., 1987) but less promising 
results for patients with alcohol dependence (mixed results from multiple trials are re-
viewed in Pettinati, 1996). In two recent, large studies of fluoxetine in combination with 
relapse prevention therapy for alcoholdependent patients, Kranzler et al. (1995) and Na-
ranjo, Bremner, and Lanctot (1995) were unable to demonstrate any significant beneficial 
effect of the active drug on alcohol consumption. The authors offered the sample constitution 
as a possible explanation for their negative finding; most patients fit an NAAL classifica-
tion, and they are less likely to show serotonergic dysfunction than AAL patients. Research-
ers also analyzed outcome results in a trial of fluoxetine; they examined an interaction 
between subtype and medication (Kranzler, Burleson, Brown, & Babor, 1996). AAL pa-
tients fared worse with active medication than with placebo, whereas no medication effect 
occurred with NAAL patients. Kranzler et al. (1996) speculated that fluoxetine may have 
agonist effects at 5-HT2C receptors that produce subjective responses resembling those of 
alcohol, as has been suggested for m-CPP (see above). Further research on the serotonergic 
dysfunction associated with AAL should be conducted, but further pharmacologic trials 
with broadly acting agents such as SSRIs are not warranted in AAL populations; agents 
targeting specific receptors might be more promising. 
Some specific serotonin receptor agents have been used in clinical trials. Ritanserin, 
primarily an antagonist of 5-HT2A receptors, showed potential usefulness in an open trial 
(Monti & Alterwain, 1991) but did not succeed in a double-blind, multisite trial (Johnson, 
Jasinski, et al., 1996). Both of these studies were with patients having moderate alcohol 
dependence. In addition, Naranjo, Poulos, et al. (1995) found little evidence of ritanseran’s 
efficacy for reducing consumption in heavy social drinkers during a 2-week trial. Ondon-
setron, a 5-HT3 antagonist, showed some efficacy in reducing drinking in a sample of 
lighter drinkers (Sellers et al., 1994). These patients were probably not AAL, but 5-HT3 is 
worthy of future investigation; 5-HT3 antagonists may decrease the reinforcing properties 
of ethanol by interfering with alcohol’s rewarding activation of the mesolimbic dopamin-
ergic system (cf. LeMarquand et al., 1994b; Sellers et al., 1994). Trials with buspirone, a 
partial agonist for 5-HT1A receptors, have been conducted with patients with comorbid 
alcoholism and anxiety disorder. Two studies showed significant reductions in both dis-
orders (Tollefson, Montague-Clouse, & Tollefson, 1992; Kranzler et al., 1994), but a third 
failed to find a benefit (Malcolm etal., 1992). 
In summary, clinical trials with serotonergic medications have had very mixed results. 
Schuckit (1996) concluded that no medication has a level of efficacy convincing enough to 
recommend it for routine use, but that naltrexone and acamprosate have shown promise. 
He suggested that dopamine boosters might have interesting possibilities and that some 
patients with comorbid psychiatric disorders may benefit from buspirone or SSRIs. Trials 
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in which patients are grouped by alcoholism subtype are lacking, however. Serotonin dys-
function is only expected to be present for the antisocial subtype of alcoholism. As de-
scribed above, abnormalities of specific receptors are also involved in this disorder, 
probably including 5-HT1B (5-HT1Dβ) and 5-HT2C. On the basis of evidence reviewed above 
from animal work, human experiments, and genetic association studies, medications af-
fecting these receptors need to be studied. Further clinical trials are not justified, however, 




There is ample evidence that the serotonin system is involved in variation among individ-
uals who have AAL, but a primary defective component is not clear. Differences in 5-HT 
level could be due to a polymorphism in TPH, the 5-HT transporter, or MAOA or MAOB. 
It is likely that there is a primary abnormality, and other dysregulation results from func-
tional alterations by serotonin neurons to compensate for one primary deficit. Differences 
in serotonin function could also be due to polymorphisms that affect binding in any of the 
receptor types. Specific syndromic manifestations (e.g., depression, anxiety, or alcoholism) 
may be due to particular receptors involved. LeMarquand et al. (1994a) speculated that 
various serotonin receptors may be involved in different components of alcohol craving 
and intake, specifically that 2A and 3 may affect reward but not consumption behavior, 2C 
may produce an intoxicated feeling, and 1A may affect both craving and consumption. 
Thus, even with normal serotonin levels, deficits could exist in postsynaptic receptors. In 
such a case, routine function may usually be adequate, but problems are revealed when 
the system is subjected to stress. Alternately, the threshold for deficient functioning under 
stress may be low, whereas less sensitive systems can better resist stress. 
Physiological studies suggest that AAL is related to lower central serotonin levels and 
lower serotonin turnover (lower CSF 5-HIAA). However, MAO activity appears lower, 
which could leave more 5-HT in the synapse, whereas transporter activity is higher, which 
would lower synaptic levels. The other consistent finding is reduced 5-HT2c receptor func-
tioning (m-CPP challenge studies). Several recent genetic studies suggest associations be-
tween alcoholism, aggression, impulsivity, and the genes for 5-HT2C and 5-HT1B receptors, 
along with markers related to synthesis (i.e., TPH) and degradation (i.e., HTTLPR, MAOA). 
Schuckit (1996) noted five proposed mechanisms for a serotonin role in alcoholism: (a) 5-HT 
activity is low in people vulnerable to alcoholism, and alcohol boosts it; (b) 5-HT contrib-
utes to the effect of alcohol on dopamine activity in reward pathways; (c) low 5-HT might 
increase impulsivity and impair self-regulation of consumption; (d) anxiety might be in-
creased by low 5-HT levels, precipitating self-medication with alcohol; and (e) 5-HT might 
be involved in general appetitive behaviors, rather than having effects specific to alcohol 
(p. 671). Kranzler and Anton (1994) proposed that serotonergic and opioidergic agents ex-
ert their consumption-reducing effect through interactions with reward pathways sub-
served by dopamine. The evidence reviewed above does not definitively falsify any of 
these proposals. There is evidence that serotonin may affect impulsivity, which would 
have general effects on appetitive behavior. Several of the serotonin receptors affect dopa-
mine reward pathways; thus, effects of these agents on alcohol consumption might be 
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mediated by dopamine. For alcohol dependence to develop, deficits in several systems 
might be required, such as a different subjective response to alcohol coupled with a dif-
ferent capacity for behavioral regulation. If so, areas for future study include combinations 
of medications and interactions among the serotonin, opiate, and dopamine systems, as 
advocated by Le, Tomkins, and Sellers (1996) and Anton (1996). 
The most relevant question to be asked in studies of the genetic basis of alcoholism is 
no longer whether there are genetic factors that influence alcoholism, but rather which 
genes are involved in the complex biopsychosocial matrix that confers vulnerability to al-
coholism. Once genes that influence vulnerability to alcoholism are identified, the question 
then becomes how those genes interact with each other and with complex and variable 
environments. Then it may be possible to develop medications that can be part of the ar-
senal of treatments for alcoholism. One strategy that will be important for identifying such 
vulnerability factors is the family-based association study in which specific allele frequen-
cies of affected cases are compared with allele frequencies of unaffected relatives for genes 
thought to be involved in the development of the trait of interest. In this article, we have 
reviewed the evidence for serotonergic system involvement in the AAL subtype, and we 
recommend further family-based studies. 
Family-based studies are superior in methods to population-based studies that com-
pare affected cases with unaffected controls (i.e., case/control studies). As mentioned ear-
lier, case/control associations between certain components of the dopaminergic system and 
alcoholism have been reported, although the findings have been inconsistent. In a meta-
analysis that pooled data from eight studies, Pato et al. (1993) found a statistically signifi-
cant association: A higher prevalence of the Al allele occurred in the alcoholism group 
(43.6%) relative to the control group (26.8%). It may be that the DRD2 receptor is a causal 
factor in alcoholism; however, Pato et al. also suggested the possibility that the observed 
association between DRD2 and alcoholism could be an artifact of the ethnic stratification 
of the affected and control groups. A potential pitfall of association studies is that positive 
associations can arise as a result of differential ethnic stratification of the affected and un-
affected groups. This confounding factor is particularly likely for genes whose allele fre-
quencies in normal populations vary considerably. If a certain allele is found more often 
in one ethnic group, and that group is over-represented in either the affected or unaffected 
group, a positive association between the trait of interest and that allele could be due to 
the allelic frequencies in those groups (Lander & Schork, 1994). The Al allele of DRD2 has 
allele frequencies between 0.09 and 0.75, and is thus prone to stratification effects (Barr & 
Kidd, 1993). Studies with ethnically homogeneous groups—for example, American Indi-
ans and Finnish Caucasians—have not found genetic associations between DRD2 and al-
coholism (Goldman et al., 1993, 1992). A recent analysis of 105 families participating in the 
COGA study (see earlier) found no evidence of an association of A1 with alcoholism (Eden-
berg et al., 1998). This study had sufficient power and rigor to eliminate definitively a pu-
tative candidate gene. 
The haplotype relative risk (HRR) method or the transmission disequilibrium test 
(TDT) should be used to reduce such spurious associations; both methods rely on compar-
isons among family members rather than between patient and control groups. In the HRR 
method (Falk & Rubenstein, 1987; Rubenstein et al., 1981), the nontransmitted parental 
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genotypes are used to create an artificial control genotype. The design requires ascertain-
ment of a single affected proband and analysis of him or her and both parents, and it is 
considered to be a very effective way to control internally for genetic admixture (Lander 
& Schork, 1994). The TDT method (McGinnis, Ewens, & Spielman, 1995; Spielman, McGin-
nis, & Ewens, 1993) involves affected probands and heterozygous parents. Both tests use a 
chi-square test statistic. Observed transmission probabilities for alleles are tested for devi-
ations from an expected probability of .50 (TDT); the HRR compares the allele distribution 
from the affected proband with that of the constructed control on the basis of the parental 
genotypes. 
The objective of our review was to present the evidence in favor of using family-based 
studies with candidate gene analysis to test the associations between components of a well-
defined biological system and a well-defined phenotype. This approach could be produc-
tive in the examination of potential associations between components of the serotonergic 
system and AAL. We reviewed the substantial evidence that the serotonin system is asso-
ciated with alcohol use and impulsivity as well as the evidence for a relatively homogene-
ous subtype of alcoholism. Association studies may help identify the specific components 
of the serotonergic system that confer vulnerability to AAL. Once identified, these compo-
nents will be logical target sites for pharmacotherapy. 
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